Our hypothesis was that, in the absence of overt brain insults, chronic activation of the IL-1 system evokes parkinsonism-related behaviors during aging, whereas impairment of IL-1 activity in casp1−/− mice results in neuroprotection and better performance. This evidence concerns the gene IL1B and Parkinson disease.